Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed London Stock Exchange - 04/24 06:17:56 am
1656.3726 GBp   +0.84%
1h ago Novartis sales miss forecast as readies overhaul
1h ago Novartis announces portfolio transformation, focusing company on leading..
2h agoDJNovartis 1Q Profit Rises About 23%
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline plc : Director/PDMR Shareholding

05/03/2012 | 02:11pm US/Eastern
Recommend:
0

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
1h ago Novartis sales miss forecast as readies overhaul
1h ago Novartis announces portfolio transformation, focusing company on leading busi..
2h agoDJNovartis 1Q Profit Rises About 23%
4h agoDJNovartis 1st Quarter Profit Rises About 23%
4h ago EXCLUSIVE : Marubeni says Chinese authorities detain three staff at grain unit
5h agoDJNovartis First-Quarter Profit Rises About 23% -- Update
1d ago Drug deals|lift shares
1d ago GLAXOSMITHKLINE : New Hydrogen Data Have Been Reported by Researchers at GlaxoSm..
1d ago GENMAB A/S : GSK and Genmab receive FDA approval for Arzerra® ofatumumab as firs..
1d ago Novartis-GSK asset swap offers template for pharma and beyond
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF